Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Novel Extended-Release Bupivacaine Polymer for Sustained Pain Relief Following Total Knee Arthroplasty

NCT07775248 is registered in ClinicalTrials.gov with Henry Ford Health System as lead sponsor.

NCT NCT07775248
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07775248 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Novel Extended-Release Bupivacaine Polymer for Sustained Pain Relief Following Total Knee Arthroplasty
Lead sponsor
Henry Ford Health System
Phase
Phase 4
Overall status
Recruiting
Start date
February 11, 2025
Completion date
October 20, 2026
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis (oa) of the knee